Serious adverse drug reactions associated with anti-SARS-CoV-2 vaccines and their reporting trends in the EudraVigilance database

Abstract A serious adverse reaction (SADR) may follow a vaccination against SARS-CoV-2 infection. We aimed to explore symptoms and reporting trends of SADRs to anti-SARS-CoV-2 vaccines based on the EudraVigilance database. This retrospective observational study analysed 250,966 suspected SADRs (with...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Wojciech Nazar, Jan Romantowski, Grzegorz Nazar, Marek Niedoszytko, Rüdiger Braun-Dullaeus, Ludmiła Daniłowicz-Szymanowicz
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2025-05-01
Sarja:	Scientific Reports
Aiheet:	SARS-CoV-2 infection COVID-19 Pharmacovigilance Vaccination Serious adverse drug reaction
Linkit:	https://doi.org/10.1038/s41598-025-03428-3
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!